The Fitness Cost of Mutations Associated with Human Immunodeficiency Virus Type 1 Drug Resistance Is Modulated by Mutational Interactions
- 15 March 2007
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (6), 3037-3041
- https://doi.org/10.1128/jvi.02712-06
Abstract
It is generally accepted that the fitness cost of resistance mutations plays a role in the persistence of transmitted drug-resistant human immunodeficiency virus type 1 and that mutations that confer a high fitness cost are less able to persist in the absence of drug pressure. Here, we show that the fitness cost of reverse transcriptase (RT) mutations can vary within a 72-fold range. We also demonstrate that the fitness cost of M184V and K70R can be decreased or enhanced by other resistance mutations such as D67N and K219Q. We conclude that the persistence of transmitted RT mutants might range widely on the basis of fitness and that the modulation of fitness cost by mutational interactions will be a critical determinant of persistence.Keywords
This publication has 20 references indexed in Scilit:
- Fitness Comparison of Thymidine Analog Resistance Pathways in Human Immunodeficiency Virus Type 1Journal of Virology, 2006
- Diversity of thymidine analogue resistance genotypes among newly diagnosed HIV-1-infected personsJournal of Antimicrobial Chemotherapy, 2005
- Transmitted Human Immunodeficiency Virus Type 1 Carrying the D67N or K219Q/E Mutation Evolves Rapidly to Zidovudine Resistance In Vitro and Shows a High Replicative Fitness in the Presence of ZidovudineJournal of Virology, 2004
- The Epidemiology of Antiretroviral Drug Resistance among Drug‐Naive HIV‐1–Infected Persons in 10 US CitiesThe Journal of Infectious Diseases, 2004
- Transmission of HIV-1 drug resistanceJournal of Clinical Virology, 2004
- Competitive Fitness of Nevirapine-Resistant Human Immunodeficiency Virus Type 1 MutantsJournal of Virology, 2004
- Progressive Reversion of Human Immunodeficiency Virus Type 1 Resistance Mutations In Vivo after Transmission of a Multiply Drug-Resistant VirusClinical Infectious Diseases, 2003
- A Novel Genetic Pathway of Human Immunodeficiency Virus Type 1 Resistance to Stavudine Mediated by the K65R MutationJournal of Virology, 2003
- Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary InfectionJournal of Virology, 2002
- RNA VIRUS MUTATIONS AND FITNESS FOR SURVIVALAnnual Review of Microbiology, 1997